Replacement therapy should be offered to adults with severe growth hormone deficiencyBMJ 1997; 314 doi: https://doi.org/10.1136/bmj.314.7080.600 (Published 22 February 1997) Cite this as: BMJ 1997;314:600
- Stephen Shaleta
- a Department of Endocrinology, Christie Hospital, Manchester M20 4BX
Editor-In 1996 adult growth hormone deficiency became a licensed indication for growth hormone replacement therapy. Under most circumstances it is not difficult to identify patients likely to have severe growth hormone deficiency. We screen this cohort and assess their need for replacement therapy. Because of current health economic policies we are unable to provide a supply of growth hormone from the hospital and therefore ask the patient's general practitioner to do this. We provide a shared care …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial